Literature DB >> 18604396

[Molecular features of breast cancer predictive of lymph node metastases].

Vanessa Fortes Zschaber Marinho1, Konradin Metze, Fernanda Squárcio Fernandes Sanches, Gislene Fátima Silva Rocha, Helenice Gobbi.   

Abstract

OBJECTIVE: The aim of our study was to analyze morphologic and molecular markers of breast cancer relating them to the presence of metastases in axillary lymph nodes.
METHODS: We selected 123 cases of invasive mammary carcinomas stratified into three subgroups: with macrometastases, with micrometastases, and lymph node negative. Presence of metastases was evaluated relating them with morphologic factors (size of primary tumor, type and grade, presence of lymphatic and blood vessel invasion in hematoxylin and eosin-stained slides) and molecular factors of primary tumor (estrogen and progesterone receptors, E-cadherin, Ki67, p53, Her2 expression, and the presence of lymphatic and blood vessel invasion in immunostained sections for D2-40 and CD31).
RESULTS: Axillary lymph node metastases were positively related to the presence of lymphatic vessel invasion in hematoxylin and eosin (H&E)-stained slides, when analyzed with or without metastases (p=0.04) and when analyzed in the three subgroups (p=0.002). Lymph node metastases were also positively related to presence of blood vessel invasion identified by immunohistochemistry (IHC) for CD31 (p=0.02). However other morphologic and molecular factors were not related to the presence of axillary node metastases.
CONCLUSION: Lymphatic and blood vessel invasion identified in H&E and IHC-stained slides are positively related to the rmetastatic status of axillary lymph nodes and are predictive of axillary lymph node metastases in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18604396     DOI: 10.1590/s0104-42302008000300011

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  3 in total

1.  Analysis of the Immunoexpression of Opioid Receptors and their Correlation with Markers of Angiogenesis, Cell Proliferation and Apoptosis in Breast Cancer.

Authors:  Alceu Machado De Sousa; Thinali Sousa Dantas; Paulo Goberlânio De Barros Silva; Conceição Da Silva Martins; Gildenio Estevam Freire; Howard Lopes Ribeiro Junior; Gerly Anne De Castro Brito; Karuza Maria Alves Pereira; Renata Ferreira De Carvalho Leitão
Journal:  Asian Pac J Cancer Prev       Date:  2021-02-01

2.  CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma.

Authors:  Karen Brajão de Oliveira; Julie Massayo Maeda Oda; Julio Cesar Voltarelli; Thiago Franco Nasser; Mario Augusto Ono; Thiago Cezar Fujita; Tiemi Matsuo; Maria Angelica Ehara Watanabe
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

3.  Myiasis associated with an invasive ductal carcinoma of the left breast: case study.

Authors:  Felipe Tavares Rodrigues; Larissa Raquel Klemig; Marcos Roberto Pereira Cardozo; Paulo Cesar Alves; Valéria Magalhães Aguiar; Claudia Soares Lessa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-06-01       Impact factor: 1.846

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.